Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / People / Aparna Kamat
Person

Aparna Kamat

Tracked across 1 events · 45 articles · First seen Jun 02, 2026 · Last active Jun 11, 2026

Sentiment
50
Attention
8
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
8 50
Tech
GLP-1 Drugs Reduce Cancer Risk
Impact: Aparna Kamat is the senior author of the study, highlighting the potential of GLP-1 RAs as cancer prevention agents, which brings her professional recognition.
Jun 02, 2026 · 45 articles
Key Actions (1)
90 Aparna Kamat published study Annals of OncologyGLP-1 Drugs Reduce Cancer Risk
ERGEN INTELLIGENCE
Track Aparna Kamat live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.